Hydrocortancyl

Quick links to important sections

Hydrocortancyl

Treatment option:

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Hydrocortancyl

Hydrocortancyl is a synthetic glucocorticoid preparation used for its profound anti-inflammatory and immunomodulatory effects. This section defines its core identity, composition, and general purpose without addressing specific dosages, conditions treated, or safety information.


Quick Facts: Hydrocortancyl Identity

Property Description
Active Ingredient Prednisolone Acetate (an ester of Prednisolone)
Form Suspension Injectable (Injection)
Pharmacological Class Glucocorticoid (Corticosteroid)
General Purpose Relief of severe inflammation and immune overactivity
Origin Synthetic derivative of natural steroid hormones

What Type of Medicine is Hydrocortancyl and Its Core Composition?

Hydrocortancyl is primarily known as a trade name for a systemic corticosteroid designed as a prescription-only medication. Its active component is prednisolone, formulated as the low-solubility prednisolone acetate which is the substance responsible for the drug's therapeutic action. This type of formulation is clinically recognized for its powerful suppression of inflammatory pathways. Glucocorticoids are derivatives of natural steroid hormones and are manufactured to achieve a significantly stronger, targeted effect, placing it within the highest tier of anti-inflammatory agents.

Understanding the Formulation: Why is Prednisolone Acetate Used as an Injection?

The drug is prepared as an aqueous suspension injectable, a liquid formulation requiring administration via systemic injection. The choice of the acetate ester is its central differentiating feature; this form possesses low solubility, allowing the medicine to be released slowly from the injection site. This design ensures a prolonged-action effect, which provides sustained relief over time, distinguishing it from immediate-release oral or soluble forms of the drug. This specific preparation guarantees the anti-inflammatory effect lasts significantly longer than standard, short-acting preparations.

The General Purpose: What Does This Glucocorticoid Primarily Help to Relieve?

The general purpose of this potent glucocorticoid is to achieve rapid and comprehensive control over intense, severe inflammation and associated immune activity. By broadly suppressing the biochemical signals that cause swelling and discomfort, Hydrocortancyl provides profound relief from the associated pain and swelling that characterize severe inflammatory states.

Regulatory References

  1. Summary of Product Characteristics (SmPC) Hydrocortancyl (HAS)

What side effects are possible with Hydrocortancyl?

Possible Side Effects and Safety Information

Hydrocortancyl (prednisolone) is a corticosteroid whose use, particularly at higher doses or for prolonged periods, is associated with a range of possible side effects spanning multiple body systems. The severity and occurrence of adverse reactions are often dose- and duration-dependent.

Key Adverse Reactions

System-Organ Class Examples of Documented Reactions
Infections/Immunity Increased susceptibility to, and masking of, new or latent infections (viral, bacterial, fungal); exacerbation of existing infections.
Endocrine/Metabolism Suppression of the hypothalamic-pituitary-adrenal (HPA) axis, Cushingoid features (e.g., "moon face," central obesity), hyperglycemia (high blood sugar), fluid retention, and potassium loss.
Musculoskeletal Osteoporosis (bone thinning) with an increased risk of fracture, muscle weakness, and loss of muscle mass.
Psychiatric Mood changes, insomnia, emotional instability, personality changes, depression, and, rarely, frank psychotic manifestations.
Ocular Posterior subcapsular cataracts and glaucoma (increased pressure in the eye).

Serious Safety Considerations

Acute Adrenal Insufficiency is a major risk upon abrupt cessation of the drug after prolonged use. This condition can be life-threatening and necessitates a gradual dosage reduction. The risk of severe infection is elevated, and Kaposi’s sarcoma has been reported in patients on corticosteroid therapy.

Restrictions and Special Populations

Hydrocortancyl is contraindicated in patients with systemic fungal infections. Caution is required in patients with pre-existing conditions such as hypertension, diabetes, peptic ulcer, heart failure, and psychiatric illness, as the drug may worsen these states. In children, prolonged use can cause irreversible growth retardation.

Overdose and Emergency Response

Overdosage with Hydrocortancyl, a systemic corticosteroid, is documented in regulatory materials as leading to a critical exaggeration of known adverse effects, primarily impacting the central nervous system and cardiovascular stability. Acute toxicity may manifest as a significant elevation of blood pressure and the development of fluid and electrolyte imbalances, which can lead to severe complications such as heart rhythm disturbances or hypokalemia.

Neurological manifestations officially listed include convulsions (seizures), dizziness, and altered mental status, such as psychosis.

Immediate medical attention is officially required if any severe symptom occurs. Regulators explicitly mandate contacting emergency services if the individual is passing out, experiencing a seizure, or exhibiting difficulty breathing.

The official standard for acute overdose treatment is entirely symptomatic and supportive therapy, as a specific pharmacologic antidote is not documented. For chronic overdosage, management protocols may include a temporary dose reduction or the introduction of an alternate-day treatment schedule. Procedural requirements for assessment often include monitoring vital signs and performing diagnostic tests like an ECG to track systemic effects.

Therapeutic Uses of Hydrocortancyl

What Hydrocortancyl Treats: Main Uses and Benefits

The medication is applied in addressing situations involving certain distressing symptoms related to inflammatory or irritative states, is applied when appropriate, in situations where symptoms may intensify temporarily. This type of glucocorticoid is considered relevant across domains where additional symptomatic support is needed.


Symptomatic Support for Acute Distress

Hydrocortancyl is commonly used across conditions presenting with acute episodes, including flares of rheumatoid arthritis, psoriatic arthritis, acute gouty arthritis, systemic lupus erythematosus (SLE), and severe allergic states. This systemic assistance is commonly used in situations involving certain distressing symptoms, such as phases of severe joint swelling, debilitating pain, or acute bronchospasm. The primary role is relevant for easing distress and provides support that helps ease the overall symptom burden.

“It is relevant in contexts involving heightened systemic burden, when symptoms interfere with daily functioning.”

Clinical Relevance and Patient Benefit

This treatment is relevant in clinical settings that involve acute or unstable symptom patterns. It may help patients cope more steadily with symptom fluctuations, and assists with maintaining functional stability when symptoms become temporarily overwhelming.


Quick Fact: Relief for Heightened Symptoms
Primary Focus: Managing symptoms related to systemic imbalance and intense physical discomfort.
Role in Care: May be part of symptomatic management during acute exacerbations.
Patient Benefit: Supports general well-ll-being during symptomatic phases.

Eligibility and Restrictions for Use

Who can and cannot use Hydrocortancyl?

The population eligibility for Hydrocortancyl (Prednisolone Acetate Injectable Suspension) is strictly defined by official regulatory criteria, focusing on absolute contraindications and specific route-based restrictions.

Contraindicated Populations

Hydrocortancyl is formally contraindicated (must not be used) in patients with the following:

  • Known Hypersensitivity to prednisolone acetate or any formulation component.
  • Systemic or Local Infection, or suspected infection, in the area of injection.
  • Severe Coagulation Disorders or those receiving specific anticoagulant treatments.
  • Premature Infants and Term Newborns due to the presence of Benzyl Alcohol.
  • Specific procedural constraints, such as the simultaneous administration of Live Vaccines.

Age and Restriction Rules

Population Group Eligibility Status (Regulatory Basis)
Newborns/Infants Contraindicated (Due to Benzyl Alcohol)
Pregnant/Lactating Women Restricted/Conditional Use (Risk assessment required)
Epidural Injection Contraindicated for specific approaches (e.g., cervical and lumbar foraminal routes)
Spinal Surgery History Restricted Use (Requires multidisciplinary review)

What should I know about interactions with other medicines?

Interactions with other medicines and products

Hydrocortancyl (prednisolone acetate) is subject to several clinically significant interactions, primarily categorized as pharmacokinetic modifications and pharmacodynamic risks, as documented in regulatory information.

Pharmacokinetic (PK) Interactions

Hydrocortancyl's active metabolite, prednisolone, is metabolized by the CYP3A4 enzyme system. The co-administration of agents that modify this enzyme activity requires careful consideration:

Interacting Substance/Class Effect on Prednisolone Levels Example Medicines
CYP3A4 Inducers Decreased (Reduced Efficacy Risk) Rifampin, Phenytoin
CYP3A4 Inhibitors Increased (Increased Adverse Effect Risk) Ketoconazole, Clarithromycin

Estrogens, including oral contraceptives, may also decrease the metabolism of prednisolone, potentially increasing exposure and effects.

Pharmacodynamic (PD) Interactions and Constraints

Combining Hydrocortancyl with certain drugs increases the risk of specific, adverse clinical outcomes:

  • NSAIDs (Non-Steroidal Anti-Inflammatory Drugs): Increased risk of gastrointestinal ulceration and bleeding.
  • Potassium-Depleting Agents (e.g., Diuretics, Amphotericin B): Increased risk of severe hypokalemia (low potassium).
  • Fluoroquinolones (e.g., Ciprofloxacin): Increased risk of tendon rupture, noted particularly in older adults.
  • Live or Live Attenuated Vaccines: Co-administration is generally restricted due to the potential for severe adverse reactions and diminished antibody response.

Mechanism of Action

Prednisolone (Hydrocortancyl) is a synthetic glucocorticoid that functions as an agonist for the intracellular glucocorticoid receptor ( GR), which is distributed across numerous cell types. Following cellular entry, the drug-receptor complex forms and then translocates into the cell nucleus. Within the nucleus, this activated complex modulates gene transcription by binding to specific DNA sequences known as glucocorticoid response elements ( GREs), altering the synthesis rate of various regulatory proteins. This is referred to as the genomic mechanism of action. A principal downstream cascade involves the inhibition of key pro-inflammatory transcription factors, specifically NF-kappa B and AP-1. This molecular modification leads to a decreased expression and subsequent reduced production of multiple inflammatory mediators, including cytokines (such as interleukins and TNF-alpha), prostaglandins, and leukotrienes. The overall system-level physiological consequence is the broad modulation of immune and inflammatory signaling pathways.

Dosage and Administration Information

How to Use Hydrocortancyl

Hydrocortancyl is an injectable sterile aqueous suspension formulated for its prolonged-action properties, which dictates a specific administration protocol and schedule. Due to the low solubility of the acetate formulation, the suspension must be shaken well prior to use to ensure uniform distribution of the active compound.


Official Administration Routes and Dosing

The approved routes are determined by the intended effect, utilizing the long-acting depot nature of the suspension. For systemic effect, the medicine is administered via deep Intramuscular (IM) injection, typically into a large muscle mass like the gluteal area. For localized effects, the injection is administered directly as Intra-articular, Intrabursal, or Intralesional injections. Intravenous (IV) or intrathecal (spinal) use is explicitly prohibited for this formulation.

Initial systemic IM doses generally range from 40 mg to 120 mg in adults. Local doses vary significantly; for example, Intra-articular doses range from 4 mg to 80 mg per joint, depending on the joint's size.


Frequency and Duration Patterns

The prolonged activity of this injectable formulation structures the dosing frequency. Systemic injections are typically spaced at weekly intervals for ongoing relief, or given as a single administration to manage an acute flare. Local injections may require repeat doses only after intervals of one to five or more weeks, based on the duration of symptomatic relief achieved. Therapy requiring long-term use is structured by the need to maintain the lowest effective dosage and requires a gradual tapering schedule upon withdrawal to minimize the risk of HPA-axis suppression.

Recent Clinical Evidence

Research evidence / Overview of Studies for Hydrocortancyl

Evidence for Use in Systemic Inflammatory Conditions

The research on Hydrocortancyl, and the general class of systemic glucocorticoids it belongs to, was evaluated in trials exploring how it is used for episodes of systemic inflammatory conditions, such as rheumatoid arthritis flares, systemic lupus erythematosus (SLE), and severe allergic states. The evidence base includes Randomized Controlled Trials (RCTs) and Systematic Reviews. Researchers explored outcomes related to physical discomfort, symptom intensity, and outcomes reflecting daily functioning or activity level. Findings describe patterns observed in the studies related to physical discomfort and systemic imbalance over a short-term duration of days to a few weeks. The overall evidence level is characterized as moderate, reflecting established clinical use based on decades of research, but the existing research is limited by being heterogeneous across different steroid formulations.

Evidence for Use in Localized Joint and Soft Tissue Inflammation

For localized inflammatory conditions such as acute gouty arthritis and bursitis, the injection was studied for outcomes related to localized pain and function. Studies explored outcomes linked to inflammatory or irritative states, focusing primarily on quantitative measurements of outcomes related to physical discomfort and daily functioning. Findings indicate patterns related to localized changes that are specific to the site of the injection. The observed changes were associated with short-to-moderate duration. A key limitation is the variability in administration methods that was observed in some studies, and research describing the long-term impact of repeated injections is limited.

What Research Gaps and Uncertainty Remain

For indications like nerve root pain (radiculalgia), where the evidence level is characterized as low, systematic reviews describe that observed changes were often associated with only small to moderate change in short-term pain scores. Furthermore, long-term effects are not fully established across all indications, and limited data are available for how symptoms evolve over multi-year periods. Research provides context but not individual predictions about how an individual will respond, and certainty remains low in areas like sustained patterns for nerve root pain.

Key Studies & References MedlinePlus Drug Information: Prednisolone Systemic

Frequently Asked Questions (FAQ)

Common questions about Hydrocortancyl (FAQ)


Q: Is Hydrocortancyl available as a cream or only as tablets?

According to the official product information, Hydrocortancyl (prednisolone acetate) is formulated exclusively as an injectable suspension. This preparation is designed for systemic (IM) or local (joint/tissue) injection only and is not available as an oral tablet or a topical cream.


Q: Can taking Hydrocortancyl make you feel jittery or anxious?

Official information for systemic corticosteroids lists several psychiatric adverse reactions. These commonly include anxiety, irritability, mood swings, and emotional instability among possible effects. If a patient experiences significant changes in mood or well-being, they should consult a healthcare professional for guidance.


Q: Is it normal to have trouble sleeping when taking Hydrocortancyl?

Yes, regulatory documents for systemic corticosteroids often list insomnia (difficulty sleeping) as a possible psychiatric side effect. This is a recognized adverse reaction that can occur during treatment with this class of medication.


Q: Are there any dietary restrictions or foods to avoid while on Hydrocortancyl?

General mandatory dietary restrictions are not typically listed for this medication. However, official warnings advise that patients with certain pre-existing conditions, such as diabetes or hypertension, may need to discuss dietary adjustments with their doctor, such as potential advice regarding salt intake.


Q: Does taking Hydrocortancyl for a short time cause weight gain?

Official documentation for corticosteroids lists both increased appetite and weight gain as general adverse reactions. These effects are typically reversible.


Q: Is Hydrocortancyl safe for teenagers or children?

The safety and effectiveness of the injectable suspension are not established for all pediatric populations. Regulatory information notes that prolonged use of corticosteroids in children is associated with a specific risk of irreversible growth retardation. Use in children and teenagers requires careful consideration and monitoring by a healthcare professional.


Q: Why do some people say they experience a 'steroid crash' when stopping Hydrocortancyl?

The term 'steroid crash' likely refers to the clinical concern of Acute Adrenal Insufficiency. This is a documented, serious risk upon abrupt discontinuation after prolonged therapy. This risk is why regulatory guidance specifies that withdrawal from prolonged use should involve a gradual dose reduction, or tapering.


Q: Does Hydrocortancyl interact with birth control pills?

Yes, official drug interaction information indicates that estrogens, including those found in oral contraceptives, can decrease how the body metabolizes prednisolone. This may lead to higher levels of the drug in the system, potentially increasing the risk of adverse reactions.


Q: Does Hydrocortancyl interact with alcohol?

Regulatory documents do not mandate abstinence from alcohol. However, official patient information often advises caution, as corticosteroids can increase the risk of gastrointestinal irritation and bleeding, which may be exacerbated by consuming alcohol.


Q: Can Hydrocortancyl be prescribed for skin conditions like eczema or psoriasis?

According to official indications, systemic corticosteroids are authorized for the palliative management of various dermatologic diseases. This can include the management of various skin diseases, such as eczema or psoriasis.


Q: Is it important to take Hydrocortancyl with food?

Since Hydrocortancyl is an injectable suspension, it is not taken orally. However, official patient counseling for oral corticosteroids often mentions that taking the medicine with food or milk may help reduce the risk of stomach upset or irritation.


Q: Does Hydrocortancyl interact with medications for high blood pressure?

Yes, corticosteroids can cause side effects like hypertension (high blood pressure) and fluid retention. Official warnings indicate that due to this risk, the patient's existing high blood pressure medication may require close monitoring or adjustment by their healthcare provider during treatment.


Q: What is the chemical classification of Hydrocortancyl?

The active ingredient in Hydrocortancyl, prednisolone, is classified in regulatory documents as a Glucocorticoid. This substance belongs to the broader class of Corticosteroids, which are synthetic derivatives of naturally occurring steroid hormones.


Q: Can Hydrocortancyl cause headaches?

Yes, regulatory documents list headache as one of the documented adverse reactions associated with systemic corticosteroid therapy.


Q: Is Hydrocortancyl a controlled substance?

No. While Hydrocortancyl is a powerful, prescription-only medication, prednisolone and its formulations are not typically classified as scheduled controlled substances in most jurisdictions.


Q: Can Hydrocortancyl interact with antifungal medications?

Yes. Many potent antifungal medications are known as CYP3A4 inhibitors. Official drug interaction warnings state that these can interfere with how your body metabolizes prednisolone, potentially increasing the concentration of the corticosteroid and raising the risk of side effects.


Q: Is it safe to use Hydrocortancyl if you have glaucoma?

Official warnings state that caution is required in patients with pre-existing conditions like glaucoma or those with a family history of it. Corticosteroids can potentially worsen the condition or cause an increase in intraocular pressure (pressure in the eye). This is why patients with glaucoma should always be assessed by a healthcare professional before starting therapy.


Q: Does Hydrocortancyl have any known effect on hair loss or growth?

Yes, regulatory documents list both hirsutism (unusual hair growth) and thinning scalp hair among the documented dermatological adverse reactions associated with corticosteroid therapy.


Q: Is there a link between Hydrocortancyl and cataracts?

Yes, official safety information indicates a link. Prolonged use of systemic corticosteroids has been associated with the development of posterior subcapsular cataracts (a specific type of clouding of the eye lens).


Q: Can Hydrocortancyl make you feel hungry or increase appetite?

Yes, increased appetite is explicitly listed in regulatory documents as a general adverse reaction associated with the use of systemic corticosteroids.


Q: Is Hydrocortancyl used for asthma or COPD flare-ups?

Official indications for systemic corticosteroids include the management of various respiratory diseases. This often covers the acute and severe stages of conditions like asthma and certain types of chronic pulmonary diseases.


Q: Does taking Hydrocortancyl affect my ability to drive or operate machinery?

Some listed side effects, such as dizziness, mood changes, or blurred vision, could potentially impair a person's judgment or physical capabilities. Official warnings indicate that patients should be aware of how they react to the medication, as these effects could potentially impair the ability to drive or operate machinery.


Q: Is it normal to feel tired or fatigued when starting Hydrocortancyl?

Regulatory documents listing side effects for systemic corticosteroids include general discomfort, malaise, and reported instances of unusual weakness or fatigue.


Q: Why does Hydrocortancyl need a prescription?

Hydrocortancyl is classified as a prescription-only medication because it is a potent glucocorticoid. It has the potential for serious adverse reactions and a need for mandatory professional oversight to ensure correct administration, appropriate monitoring, and proper dose management.


Q: What should I do if my symptoms worsen after starting Hydrocortancyl?

Patient counseling documents consistently advise that a patient should contact their doctor or healthcare provider if their original symptoms worsen, fail to improve, or if they develop any new health concerns during treatment.


How should Hydrocortancyl be stored and disposed of?

Official Storage and Disposal Requirements

This information is based strictly on government regulatory documents outlining the required storage, stability, and disposal procedures for injectable hydrocortisone preparations.

Requirement Official Statement Summary
Temperature Store below 25 C (e.g., controlled room temperature).
Light Protection Keep the ampoules in the outer carton to protect the product from light.
Child Safety Keep out of the sight and reach of children.
Stability After Prep Prepared or diluted solutions must be used only if they are clear, and should generally be used within 12 to 24 hours, depending on the specific storage temperature (room or refrigerated).
Disposal Any unused medicinal product, waste materials, and containers must be disposed of in accordance with local requirements for pharmaceutical waste.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Hydrocortancyl found in:

A-Z Index: